Overexpression of DLEU2L and miR-210-3p interference effectively inhibited pancreatic tumor progression, indicating that DLEU2L plays a crucial role in miR-210-3p-mediated GEM resistance. Here, DLEU2L is linked to pancreatic neoplasm.